D
DAWN
Day One Biopharmaceuticals, Inc.
21.44
-0.02-0.09%After Hours: 21.44 0.00 0.00%19:41 04/08 EDT
OPEN/PREV CLOSE21.46/21.46
TODAY RANGE21.42-21.46
VOL1.52M
MARKET CAP2.21B
52 WEEK RANGE5.64-21.47
AVG VOL (3M)4.46M
% TURNOVER1.47%
TURNOVER--
P/E (TTM)-20.6174
% RANGE0.19%
EPS(TTM)-1.0399
P/E(FORWARD)-29.7778
P/B5.00
BVPS4.284
DIVIDEND--
P/S13.96
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.80B
SHARES OUTSTANDING103.30M
NEXT EARNINGS05/01-05/07
FREE FLOAT83.84M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Biotech Is Holding Steady In 2026
Seeking Alpha·03/23 18:47
Top performing mid-cap stocks YTD as volatility hits markets
Simply Wall St·03/12 01:34
Servier All Cash Deal Reframes Day One Biopharmaceuticals Valuation Story
Benzinga·03/11 14:34
This VICI Properties Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday
Dow Jones·03/11 14:26
Day One Biopharm Price Target Cut to $21.50/Share From $27.00 by JP Morgan
Dow Jones·03/11 14:26
Day One Biopharm Cut to Neutral From Overweight by JP Morgan
TipRanks·03/11 13:45
Oracle, Nike upgraded: Wall Street’s top analyst calls
TipRanks·03/10 21:05
Day One downgraded to Neutral from Overweight at JPMorgan
TipRanks·03/10 13:35
Qualcomm downgraded, Rivian upgraded: Wall Street’s top analyst calls
Benzinga·03/10 13:17
This Day One Biopharmaceuticals Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Dow Jones·03/10 11:10
Day One Biopharm Cut to Neutral From Buy by HC Wainwright & Co.
Dow Jones·03/10 11:10
Day One Biopharm Price Target Cut to $21.50/Share From $22.00 by HC Wainwright & Co.
Same Industry
Name/Symbol
Change%
Price